TY - JOUR
T1 - Review on biphasic blood drying method for rapid pathogen detection in bloodstream infections
AU - Lim, Jongwon
AU - Koprowski, Katherine
AU - Wester, Matthew
AU - Valera, Enrique
AU - Bashir, Rashid
N1 - J.L. acknowledges support from the SLAS Innovation award and SLAS2024 TONY B. travel award, made by the Society for Laboratory Automation and Screening. The authors acknowledge support from the Jump ARCHES (Applied Research through Community Health through Engineering and Simulation) endowment through the Health Care Engineering Systems Center at UIUC and OSF, from the Dynamic Research Enterprise for Multidisciplinary Engineering Sciences (DREMES) Center funded by the Zhejiang University of Illinois ZJUI Joint Institute , from the National Institutes of Health ( R01AI148385 and R01 EB032725 A ). The authors thank the staff at the Holonyak Micro and Nanotechnology Laboratory at UIUC for facilitating the research and the funding from University of Illinois.
PY - 2025/6
Y1 - 2025/6
N2 - Rapid and accurate detection of pathogenic microorganisms in blood is critical for diagnosing life-threatening conditions such as bloodstream infections (BSIs). Current methods for the detection and identification of bacteria from large volumes of blood (5 mL) involve culture steps followed by DNA extraction/purification/concentration and Polymerase Chain Reaction (PCR)-based nucleic acid amplification. DNA extraction and amplification directly from blood samples is hampered by the complexity of the blood matrix, resulting in time-consuming and labor-intensive processes. This review delves into recent advancements in molecular diagnostics based on blood drying, coined as ‘biphasic reaction’, and highlights this new technique that attempts to overcome the limitations of traditional sample preparation and amplification processes. The biphasic blood drying method, in combination with isothermal amplification methods such as loop-mediated isothermal amplification (LAMP) or recombinase polymerase amplification (RPA), has recently been shown to improve the sensitivity of detection of bacterial, viral, and fungal pathogens from ∼1 mL of whole blood, while minimizing DNA loss and avoiding the use of extraction/purification/concentration kits. Furthermore, the biphasic approach in combination with LAMP has been shown to be a culture-free method capable of detecting bacteria in clinical samples with a sensitivity of ∼1 CFU/mL in ∼2.5 h. This represents a significant reduction in detection and identification time compared to current clinical procedures based on bacterial culture prior to PCR amplification. This review paper aims to be a guide to identify new opportunities for future advancements and applications of the biphasic technology.
AB - Rapid and accurate detection of pathogenic microorganisms in blood is critical for diagnosing life-threatening conditions such as bloodstream infections (BSIs). Current methods for the detection and identification of bacteria from large volumes of blood (5 mL) involve culture steps followed by DNA extraction/purification/concentration and Polymerase Chain Reaction (PCR)-based nucleic acid amplification. DNA extraction and amplification directly from blood samples is hampered by the complexity of the blood matrix, resulting in time-consuming and labor-intensive processes. This review delves into recent advancements in molecular diagnostics based on blood drying, coined as ‘biphasic reaction’, and highlights this new technique that attempts to overcome the limitations of traditional sample preparation and amplification processes. The biphasic blood drying method, in combination with isothermal amplification methods such as loop-mediated isothermal amplification (LAMP) or recombinase polymerase amplification (RPA), has recently been shown to improve the sensitivity of detection of bacterial, viral, and fungal pathogens from ∼1 mL of whole blood, while minimizing DNA loss and avoiding the use of extraction/purification/concentration kits. Furthermore, the biphasic approach in combination with LAMP has been shown to be a culture-free method capable of detecting bacteria in clinical samples with a sensitivity of ∼1 CFU/mL in ∼2.5 h. This represents a significant reduction in detection and identification time compared to current clinical procedures based on bacterial culture prior to PCR amplification. This review paper aims to be a guide to identify new opportunities for future advancements and applications of the biphasic technology.
UR - http://www.scopus.com/inward/record.url?scp=105004652466&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105004652466&partnerID=8YFLogxK
U2 - 10.1016/j.slast.2025.100276
DO - 10.1016/j.slast.2025.100276
M3 - Review article
C2 - 40127716
AN - SCOPUS:105004652466
SN - 2472-6303
VL - 32
JO - SLAS Technology
JF - SLAS Technology
M1 - 100276
ER -